NetworkNewsBreaks

ThursdayNov 21, 2019 11:07 am

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Secures Network Approval, Anticipates Near-Term Commercial Launch of UV350 with Additional Tier 1 US Cellular Carrier

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of network approval for the Uniden(R) UV350 dedicated in-vehicle smartphone from an additional Tier 1 cellular carrier in the United States. Per the update, Siyata anticipates commercial launch of the UV350 with this Tier 1 U.S. cellular carrier to be completed soon. “We are very excited to be working with another one of the largest cellular carriers in the United States to provide first responder and enterprise customers access to in-vehicle technology that offers more features and increased safety for much less cost than land mobile radio solutions,” Siyata Mobile…

Continue Reading

ThursdayNov 21, 2019 10:48 am

NetworkNewsBreaks – ChineseInvestors.com Inc. (CIIX) to Host Investor Conference Call This Afternoon

ChineseInvestors.com Inc. (OTCQB: CIIX) this morning announced that it will host an investor conference call today, Novemebr 21, 2019, at 4:00 p.m. EST. Per the update, the call will focus on recent company developments. CEO Warren Wang will be on the call to provide insight into CIIX’s fast-growing industrial hemp/CBD business in China, as well as the company’s legacy financial news and information business. To join the call, interested parties should dial (866) 821-0302. To view the full press release, visit http://nnw.fm/ZVQo9 About ChineseInvestors.com Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis…

Continue Reading

ThursdayNov 21, 2019 10:22 am

NetworkNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Issues Update Following Milestone Cannabis Decision by House Judiciary Committee

Cannabis Strategic Ventures Inc. (OTCQB: NUGS) this morning issued an update applauding House Judiciary Committee members for taking a significant step toward the legalization of the cannabis market through the passage of the Marijuana Opportunity Reinvestment and Expungement Act of 2019 (“MORE Act”), which will now move to the House for full consideration. “The ramifications of this bill bring excitement to the cannabis industry,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “Removing federal legislative obstacles brings tremendous opportunity in scaling the cannabis industry and we applaud the members of the House Judiciary Committee for their…

Continue Reading

ThursdayNov 21, 2019 10:22 am

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Enhanced Technology Shows Rapid Onset of Action in Under 10 Minutes

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its development of additional enhancements for its industry-leading DehydraTECH(TM) platform that delivers THC onset of action in less than 10 minutes in human pilot testing. According to the update, volunteers in recent human subjective pilot tests reported onset in less than 10 minutes from edibles formulated with this latest DehydraTECH innovation. This enhanced version of the delivery platform shows onset that is roughly twice as fast as traditional DehydraTECH and four to six times faster than generic industry formulations. To view the full press release,…

Continue Reading

ThursdayNov 21, 2019 10:13 am

NetworkNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Announces Strategic Appointments to Management Team, Advisory Board

Green Hygienics Holdings (OTCQB: GRYN), an innovative premium cannabis cultivation and branding enterprise, today announced the appointment of four experienced professionals to its leadership team. New management team and advisory board members include Senior VP of Business Development, Agriculture Division Jerry Halamuda, Senior VP of Corporate Development John Gildea, Independent Director William Creekmur MBA, and Advisory Board Member Edwin Stoughton. “Each of the professionals joining our team adds considerable value to GRYN’s growth strategy,” GRYN CEO Ron Loudoun said in the news release. “The industrial hemp industry is paced for revolutionary progress, and I am pleased to welcome these gentlemen…

Continue Reading

ThursdayNov 21, 2019 9:47 am

NetworkNewsBreaks – No Borders Inc. (NBDR) CEO Presents CBD LabChain Platform at Blockchain Expo 2019

Multifaceted holding corporation No Borders Inc. (OTC: NBDR) this morning announced that it has successfully developed and deployed a revolutionary blockchain platform for securely and immutably recording cannabinoid lab test data on its new public blockchain. The company presented this new platform at Blockchain Expo 2019, gaining immediate exposure to a wide audience of industry leaders and professionals. “No Borders is strongly committed to shareholder value, and the deployment of CBD LabChain is a prime example of our ability to successfully operate in a high growth, high profit vertical while strategically dissecting that vertical for scalable technological solutions to in-vertical…

Continue Reading

ThursdayNov 21, 2019 9:37 am

NetworkNewsBreaks – Spectrum Global Solutions, Inc. (SGSI) Releases Q3 2019 Financial Results

Spectrum Global Solutions (OTCQB: SGSI), a leading single-source provider of next-generation communications network, technology, infrastructure and maintenance solutions, on Wednesday reported financial results for the third quarter ended September 30, 2019. Within the update, the company highlighted closing of the WaveTech GmbH acquisition, which will enable Spectrum to better monetize its existing customer base while expanding into new global markets through WaveTech’s current relationships. “The third quarter of 2019 was highlighted by our transformational acquisition of WaveTech, additionally marked by our continued aggregation of new contract wins in the race to deploy 5G networks nationwide,” Spectrum Global Solutions CEO Roger…

Continue Reading

ThursdayNov 21, 2019 9:32 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces $1.26M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company, on Wednesday announced a registered direct offering of 3,167,986 shares of its common stock at a price of $0.40 each, for gross proceeds of about $1.26 million prior to deduction of commissions and offering expenses. In a concurrent private placement, Genprex agreed to issue unregistered warrants to purchase up to 3,167,986 shares to the investors in the registered direct offering. The warrants, which have an exercise price of $0.46 per share, will be exercisable six months from the issuance date and will expire after five years. The warrants will be exercisable for…

Continue Reading

WednesdayNov 20, 2019 3:24 pm

NetworkNewsBreaks – Dow Jones & Factiva Insider Introduce Factiva 2020 Campaign

Multifaceted financial news and publishing company InvestorBrandNetwork (“IBN”), which includes Dow Jones and Factiva among its syndication partners, is highlighting the 20th anniversary of the Factiva brand and the official start of the Factiva 2020 campaign. The brand anniversary and Factiva 2020 are celebrated in the current Dow Jones / Factiva Insider. “Over the last year, we have been working on Factiva’s technical platform, modernizing it and moving it to the cloud — all resulting in a more scalable and stable research tool,” Head of Factiva Product Strategy Brian Gelinas stated in the publication. “We are ready for the next…

Continue Reading

WednesdayNov 20, 2019 2:43 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Secures $15 Million Equity Line

Predictive Oncology (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its entry into a $15 million common stock purchase and registration rights agreement with Oasis Capital, LLC, a Puerto Rico limited liability company. Under the agreement, upon satisfaction of its conditions including the effectiveness of a resale registration statement, which has occurred, Predictive Oncology has the right to sell up to $15 million of its common stock to Oasis Capital over a 36-month period. “With this equity line established, the financial road ahead for Predictive Oncology has truly begun to smooth out,“…

Continue Reading